biblio

Export 15 results:
Filters: Keyword is Mycobacterium tuberculosis  [Clear All Filters]
2005
U. Singh, Panchanadikar, V., and Sarkar, D., “Development of a simple assay protocol for high-throughput screening of mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 10, no. 7, pp. 725-729, 2005.
2006
U. Singh and Sarkar, D., “Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel inhibitors”, Journal of Biomolecular Screening, vol. 11, no. 8, pp. 1035-1042, 2006.
2009
M. K. Gurjar, Reddy, C. Nageswar, Kalkote, U. R., and Chorghade, M. S., “Studies toward the total synthesis of carba analogue of motif C OF M. TB cell wall AG complex”, Heterocycles, vol. 77, no. 2, pp. 909-925, 2009.
2011
U. Singh, Akhtar, S., Mishra, A., and Sarkar, D., “Novel screening method based on menadione mediated rapid reduction of tetrazolium salt for testing of anti-mycobacterial agents”, Journal of Microbiological Methods, vol. 84, no. 2, pp. 202-207, 2011.
M. Muthukrishnan, Mujahid, M., Yogeeswari, P., and Sriram, D., “Syntheses and biological evaluation of new triazole-spirochromone conjugates as inhibitors of mycobacterium tuberculosis”, Tetrahedron Letters, vol. 52, no. 18, pp. 2387-2389, 2011.
2012
R. R. Kulkarni, Shurpali, K., Gawade, R. L., Sarkar, D., Puranik, V. G., and Joshi, S. P., “Phyllocladane diterpenes from anisomeles heyneana”, Journal of Asian Natural Products Research, vol. 14, no. 12, pp. 1162-1168, 2012.
S. Sarkar and Sarkar, D., “Potential use of nitrate reductase as a biomarker for the identification of active and dormant inhibitors of mycobacterium tuberculosis in a THP1 infection model”, Journal of Biomolecular Screening, vol. 17, no. 7, pp. 966-973, 2012.
2013
M. Mujahid, Gonnade, R. G., Yogeeswari, P., Sriram, D., and Muthukrishnan, M., “Synthesis and antitubercular activity of amino alcohol fused spirochromone conjugates”, Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 5, pp. 1416-1419, 2013.
2015
A. C. Lele, Raju, A., Khambete, M. P., Ray, M. K., Rajan, M. G. R., Arkile, M. A., Jadhav, N. J., Sarkar, D., and Degani, M. S., “Design and synthesis of a focused library of diamino triazines as potential mycobacterium tuberculosis DHFR inhibitors”, ACS Medicinal Chemistry Letters, vol. 6, no. 11, pp. 1140-1144, 2015.
J. M. Gajbhiye, More, N. A., Patil, M. D., Ummanni, R., Kotapalli, S. S., Yogeeswari, P., Sriram, D., and Masand, V. H., “Discovery of rimonabant and its potential analogues as anti-TB drug candidates”, Medicinal Chemistry Research, vol. 24, no. 7, pp. 2960-2971, 2015.
R. Vyas, Karthikeyan, M., Nainaru, G., and Muthukrishnan, M., “Pharmacophore and docking based virtual screening of validated mycobacterium tuberculosis targets”, Combinatorial Chemistry & High Throughput Screening, vol. 18, no. 7, pp. 624-637, 2015.
2021
R. Balasaheb Aher and Sarkar, D., “Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating Mycobacterium tuberculosis”, Journal of Biomolecular Structure & Dynamics, vol. 39, no. 3, pp. 889-900, 2021.
Y. K. Abhale, Shinde, A., Shelke, M., Nawale, L., Sarkar, D., and Mhaske, P. C., “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
2022
S. Sarkar, Swami, S., Soni, S. Kumar, Holien, J. K., Khan, A., Korwar, A. M., Likhite, A. P., Joshi, R. A., Joshi, R. R., and Sarkar, D., “Detection of a target protein (GroEl2) in Mycobacterium tuberculosis using a derivative of 1,2,4-triazolethiols”, Molecular Diversity, vol. 26, no. 5, pp. 2535-2548, 2022.
J. L. Nalawade, Mhaske, P. C., Shinde, A. D., Chavan, A. P., Abhale, Y. K., Sarkar, D., and Bobade, V. D., “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.